Phospho-AMOT(S1041) Antibody Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q4VCS5 |
---|---|
Clone Names | 111212008 |
Gene ID | 154796 |
---|---|
Other Names | Angiomotin, AMOT, KIAA1071 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | AMOT |
---|---|
Synonyms | KIAA1071 |
Function | Plays a central role in tight junction maintenance via the complex formed with ARHGAP17, which acts by regulating the uptake of polarity proteins at tight junctions. Appears to regulate endothelial cell migration and tube formation. May also play a role in the assembly of endothelial cell-cell junctions. |
Cellular Location | Cell junction, tight junction. Note=Localized on the cell surface. May act as a transmembrane protein |
Tissue Location | Expressed in placenta and skeletal muscle. Found in the endothelial cells of capillaries as well as larger vessels of the placenta. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene belongs to the motin family of angiostatinbinding proteins characterized by conserved coiled-coil domains andC-terminal PDZ binding motifs. The encoded protein is expressedpredominantly in endothelial cells of capillaries as well as largervessels of the placenta where it may mediate the inhibitory effectof angiostatin on tube formation and the migration of endothelialcells toward growth factors during the formation of new bloodvessels. Alternative splicing results in multiple transcriptvariants encoding different isoforms.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Heller, B., et al. J. Biol. Chem. 285(16):12308-12320(2010)Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)Gagne, V., et al. Cell Motil. Cytoskeleton 66(9):754-768(2009)Zheng, Y., et al. Circ. Res. 105(3):260-270(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.